Related Experiment Video
Updated: Jul 15, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a
International Journal of Cardiology
|April 17, 2007
Summary
The apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism is not significantly linked to myocardial infarction risk. However, the epsilon2 allele and epsilon2epsilon3 genotype showed a trend towards reduced risk compared to epsilon3epsilon3.
Area of Science:
- Genetics and Cardiovascular Disease
- Molecular Biology
- Epidemiology
Background:
- The association between apolipoprotein E (APOE) gene polymorphisms (epsilon2, epsilon3, epsilon4) and myocardial infarction (MI) remains inconclusive.
- Previous studies have yielded conflicting results regarding the impact of APOE isoforms on MI risk.
- This study investigates the APOE epsilon2/epsilon3/epsilon4 polymorphism in relation to MI within a large case-control cohort.
Discussion:
- Our large-scale case-control study found no statistically significant association between APOE epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction.
- While not statistically significant, a trend towards a reduced risk of MI was observed for individuals carrying the epsilon2 allele or the epsilon2epsilon3 genotype compared to the common epsilon3epsilon3 genotype.
- These findings suggest that while APOE genotype may not be a primary driver of MI, subtle protective effects of certain alleles warrant further investigation.
Key Insights:
- No statistically significant link was found between APOE epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction.
- A trend towards lower myocardial infarction risk was observed for the epsilon2 allele and epsilon2epsilon3 genotype.
- The epsilon3epsilon3 genotype appears to represent a baseline risk within this population.
Outlook:
- Further research with larger, diverse populations is needed to confirm the observed trends and elucidate the biological mechanisms underlying the potential protective effects of the epsilon2 allele.
- Investigating gene-environment interactions may provide deeper insights into the role of APOE in cardiovascular disease.
- Future studies could explore other genetic and non-genetic factors that modulate the relationship between APOE and myocardial infarction.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...